N/A N=38 Efficacy of Capacitive-Resistive Therapy on the Treatment of Myofascial Pain
Myofascial Pain Syndrome of Neck
Primary: Visual Analog Scale (VAS) Score Change — 5.9; 5.1; 4.1; 2.3 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=74 The Effectiveness of a Physiotherapy Technique in Patients With Chronic Myofascial Temporomandibular Disorder
Myofascial Pain Syndrome · Temporomandibular Disorder
Primary: Changes of Perceived Pain Between Three Time Points (Baseline, Post-treatment, and 3 Months Later) and Between Groups (Sham Simulation and Pressure Release Technique)…
N/A N=48 Percutaneous Microelectrolysis on Myofascial Trigger Points Pain.
Myofascial Trigger Point Pain (MTrP)
Primary: Pain Pressure Threshold (PPT) — 1.4; 1.4; 1.6; 1.6 Kg/cm2
Phase 4 N=127 Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy.
Myofascial Pain Syndrome · Pain · Myofascial Trigger Point Pain
Primary: Visual Analogue Scale — 40.8; 44.2; 37.8 units on a scale
N/A N=131 Dry Needling in Patients With Chronic Neck Pain
Neck Pain
Primary: Change in Pain Scores on the Visual Analog Scale (VAS: 0-10) After 30 Days — 1.77; 3.34; 8.83 units on a scale
Phase 2 N=11 Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty
Trigger Point Pain, Myofascial
Primary: Pain Scores on the Visual Analog Scale — 51; 55; 40; 42 Pain Scores on the Visual Analog Scale
N/A N=30 Efficacy of Dry Needling in Plantar Fasciitis
Fasciitis, Plantar
Primary: Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View. — 5.3; 4.7 millimeters
N/A N=42 Quantifying Myofascial Dysfunction in Post-Stroke Pain
Myofascial Dysfunction
Primary: T1 Rho MRI Relaxation Time of Shoulder External Rotator (Milliseconds) — 29.09; 27.15 milliseconds
N/A N=828 Multiple Areas of Pain (MAP)
Chronic Pain
Primary: Multi-site Pain Index — 0.52 units on a scale
N/A N=62 Repetitive Transcranial Magnetic Stimulation for Musculoskeletal Pain in Patients With Parkinson's Disease
Parkinson's Disease · Musculoskeletal Pain · Repetitive Transcranial Magnetic Stimulation
Primary: Change From Baseline Over 2 Months (Group by Time Interaction) in Modified KING'S PD Pain Scale Domain 1 — 12.41; 13.64; 9.96; 14.71 units on a scale
N/A N=88 PECS II vs. MTP for Analgesia After MRM
Breast Neoplasm Female · Postoperative Pain Management
Primary: Post-operative Pain Severity Assessed by VAS at Hour-4 — 1.4; 2.2 score on a scale
N/A N=43 Transcutaneous Electrical Nerve Stimulation (TENS) and Fibromyalgia (FM)
Fibromyalgia
Primary: Pain at Rest Difference Score Pre-intervention and Post Intervention — 0.38; -0.74; -0.47 units on a scale
N/A N=9 Transcranial Magnetic Stimulation for Facial Pain
Trigeminal Nerve Injuries · Post-herpetic Neuralgia · Facial Pain
Primary: Visual Analogue Scale (VAS) — 5.4 score on a scale
N/A N=20 Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Lower Back Pain
Primary: Immediate Pain Measured by Numeric Pain Rating Scale (NPRS) — 4.89; 5.18 score on a scale
N/A N=40 Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia
Pelvic Floor Muscle Spasm
Primary: Visual Analog Pain Score After 6 Weekly Injections — 3.33; 2.99 Visual Analog Pain Score
N/A N=20 Cramer Sports Motion Tape and Low Back Pain EMG
Low Back Pain
Primary: Percent of Maximal Voluntary Isometric Contraction (%MVIC) — 226.41; 250.51; 162.47; 205.82 % of Max Voluntary Isometric Contraction
N/A N=22 Effect of Inhibitory Kinesio-tape of the Upper Trapezius on Lower Trapezius Muscle Excitation
Scapular Dyskinesis
Primary: Whole-muscle Activation — .046; .043; .040; .061 V
N/A N=17 TMS Treatment for Pain in Chronic Pancreatitis
Idiopathic Chronic Pancreatitis · Pain
Primary: Pain (Visual Analog Scale, CGI, PGA) — 7; 0 number of participants w/ reduced pain
N/A N=116 Mindful Action for Pain
Chronic Pain
Primary: Brief Pain Inventory (BPI) Pain Interference Subscale Change — 6.77; 7.31; 7.38; 5.40 units on a scale
N/A N=30 Cervical Activation During Elastic and Manual Resistance
Cervical Pain
Primary: Percent of Peak Activation (%PA) — 51.72; 61.20; 88.1; 80.80 Percentage of Peak Activation (%PA)
Phase 2 N=19 Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain
Fibromyalgia · Chronic Pain · Depression
Primary: Gracely Box Intensity Rating Scale — 13.18; 14.43; 10.64; 13.00 units on a scale
N/A N=47 Evaluation of the Efficacy of the Use MD Tissue Collagen Medical Device in the Infiltrative Treatment of Greater Trochanter Pain Syndrome (GTPS)
Greater Trochanteric Pain Syndrome · GTPS - Greater Trochanteric Pain Syndrome · Tendon Disorder
Primary: Change in NRS (Numerical Rating Scale) Pain Score From Baseline (Week 0) to Week 10 — 4.7 NRS Pain Score (range 0-10; higher score
N/A N=28 Effects of Transcranial Magnetic Stimulation (TMS) and Stimulus Controllability on Pain Perception
Chronic Pain
Primary: Pain Unpleasantness During Perceived Control Condition — 54.5; 60.5 units on a scale
N/A N=301 Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
Fibromyalgia
Primary: Pain Rating With Movement (0-10 Low to High Scale) During Six Minute Walk Test — -1.8; -0.8; 0.00; -2.0 Units on a scale — p=0.008
N/A N=28 Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: Randomized Single Blinded Investigational Trial
Temporomandibular Joint Dysfunction Syndrome
Primary: Self Report of Pain — -.86; -2.0; -1.4; -1.3 Scores on pain intensity scale — p=0.17
N/A N=16 Hippocampal Stimulation in Chronic Low Back Pain
Chronic Pain · Back Pain · Pain
Primary: Changes in Pain Scales — 4.6; 4.6; 4; 4.4 units on a scale
N/A N=20 Visceral Manipulation in Patients With Chronic Low Back Pain
Chronic Low Back Pain
Primary: Low Back Pain After 6 Weeks of Intervention — 6.50; 6.00; 1.50; 3.50 units on a scale
Phase 3 N=75 Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles
Pain, Head · Pain Syndrome · Temporomandibular Disorder
Primary: Change in Jaw Pain as Reported by Patient on Visual Analog Scale (VAS) — 58; 54; -19; -14 score on a scale — p=0.80
Phase 2 N=51 Effectiveness of Photobiomodulation and Manual Therapy Alone or Combined in TMD Patients
Temporomandibular Disorder
Primary: Change From Baseline in Visual Analogic Scale (VAS) for Pain — 4.1; 4.4; 5.2; 3.3 millimeters — p=<0.001
N/A N=23 Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain
Cervical Radiculopathy
Primary: Upper Limb Neurodynamic Tesnion (UNLT) Range of Motion — 4.60; 16.00 degrees